Literature DB >> 11791917

Synthesis of blood compatible polyamide block copolymers.

Jai Paul Singhal1, Alok R Ray.   

Abstract

Blood compatibility of polyamides has been improved by introducing amido-amine groups in polymer backbone. Polyamide block-copolymer are synthesized by reacting amine end-capped polyamides with N,N'-methylene-bisacrylamide. Polyamide block-copolymers, thus produced found to have the ability of absorbing heparin. Heparinized polyamide block-copolymers have shown significant improvement in blood compatibility as evident from thrombus formation and hemolysis studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11791917     DOI: 10.1016/s0142-9612(01)00228-9

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  13 in total

1.  Biocorrosion properties and blood and cell compatibility of pure iron as a biodegradable biomaterial.

Authors:  Erlin Zhang; Haiyan Chen; Feng Shen
Journal:  J Mater Sci Mater Med       Date:  2010-04-16       Impact factor: 3.896

2.  Preparation and blood coagulation evaluation of chitosan microspheres.

Authors:  Qi Zhao Wang; Xi Guang Chen; Zi Xiang Li; Song Wang; Cheng Sheng Liu; Xiang Hong Meng; Chen Guang Liu; Ying Hui Lv; Le Jun Yu
Journal:  J Mater Sci Mater Med       Date:  2007-10-04       Impact factor: 3.896

3.  Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer.

Authors:  Ye Liang; Yonghua Wang; Liping Wang; Zhijuan Liang; Dan Li; Xiaoyu Xu; Yuanbin Chen; Xuecheng Yang; Hongbo Zhang; Haitao Niu
Journal:  Bioact Mater       Date:  2020-09-08

4.  Biocompatibility study of theophylline/chitosan/beta-cyclodextrin microspheres as pulmonary delivery carriers.

Authors:  Wei Fen Zhang; Hui Yun Zhou; Xi Guang Chen; Shu Hong Tang; Jing Jing Zhang
Journal:  J Mater Sci Mater Med       Date:  2009-01-10       Impact factor: 3.896

5.  α-Santalol functionalized chitosan nanoparticles as efficient inhibitors of polo-like kinase in triple negative breast cancer.

Authors:  Jinku Zhang; Yanan Wang; Jinmei Li; Wenming Zhao; Zhao Yang; Yanguang Feng
Journal:  RSC Adv       Date:  2020-02-03       Impact factor: 4.036

6.  Evaluation of hemagglutination activity of chitosan nanoparticles using human erythrocytes.

Authors:  Jefferson Muniz de Lima; Ronaldo Rodrigues Sarmento; Joelma Rodrigues de Souza; Fábio André Brayner; Ana Paula Sampaio Feitosa; Rafael Padilha; Luiz Carlos Alves; Isaque Jerônimo Porto; Roberta Ferreti Bonan Dantas Batista; Juliano Elvis de Oliveira; Eliton Souto de Medeiros; Paulo Rogério Ferreti Bonan; Lúcio Roberto Castellano
Journal:  Biomed Res Int       Date:  2015-02-11       Impact factor: 3.411

7.  Curcuma mangga-Mediated Synthesis of Gold Nanoparticles: Characterization, Stability, Cytotoxicity, and Blood Compatibility.

Authors:  Yiing Yee Foo; Vengadesh Periasamy; Lik Voon Kiew; G Gnana Kumar; Sri Nurestri Abd Malek
Journal:  Nanomaterials (Basel)       Date:  2017-05-27       Impact factor: 5.076

8.  In Vitro Effect of Cinnamomum zeylanicum Blume Essential Oil on Candida spp. Involved in Oral Infections.

Authors:  Marianne de Lucena Rangel; Sabrina Garcia de Aquino; Jefferson Muniz de Lima; Lúcio Roberto Castellano; Ricardo Dias de Castro
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-17       Impact factor: 2.629

9.  pH-Responsive Charge-Conversional and Hemolytic Activities of Magnetic Nanocomposite Particles for Cell-Targeted Hyperthermia.

Authors:  Md Abdur Rahman; Yoshimasa Matsumura; Shigekazu Yano; Bungo Ochiai
Journal:  ACS Omega       Date:  2018-01-25

10.  Gold Nanoparticles Prepared with Phyllanthus emblica Fruit Extract and Bifidobacterium animalis subsp. lactis Can Induce Apoptosis via Mitochondrial Impairment with Inhibition of Autophagy in the Human Gastric Carcinoma Cell Line AGS.

Authors:  Rongbo Wang; Xingyue Xu; Aditi Mitra Puja; Haribalan Perumalsamy; Sri Renukadevi Balusamy; Hoon Kim; Yeon-Ju Kim
Journal:  Nanomaterials (Basel)       Date:  2021-05-11       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.